Cure Alzheimer's Fund Cure Alzheimer's Fund
  • The Disease
    • Pathology
    • Signs & Symptoms
    • Risk Factors
    • Early Onset
    • Dementia
    • Women & Alzheimer’s
    • Detection
    • Stats & Costs
  • The Research
    • Areas of Focus
      • Alzheimer’s Genome Project
      • Genes to Therapy / Stem Cell Screening
      • Identification
      • Immune System Structures & Processes
      • Interaction of the Microbiome
      • Pathological Pathways & Systems
      • Therapeutic Strategies & Drug Discovery
      • Whole Genome Sequencing
      • Other Areas of Investigation
    • Consortia
      • 3DDS
      • APOE
      • Circuits
      • Women & Alzheimer’s
    • Funded Projects
    • Grant Process
    • Our Researchers
    • Topics of Interest
      • Alzheimer’s in a Dish
      • Amyloid Hypothesis
      • Amyloid Precursor Protein
      • Brain Lymphatic System
      • Innate Immunity
      • Microglia
      • Blood Brain Barrier
    • Published Papers
    • Discoveries
  • About Us
    • Our Story
    • Our People
    • Reports
  • Giving
    • Donate
    • Ways to Donate
      • Planned Giving
    • 2019 Annual Appeal
    • Heroes & Heroines
    • In Memory & In Honor
    • Artists Giving Back
    • Charity Watchdogs
  • News and Events
    • Events
      • 2018 Symposium Video
    • Webinars
    • Interviews
    • Press
    • Videos
    • Research Newsletter
      • Fall 2020
      • March 2020
      • November 2019
      • October 2019
      • July 2019
      • March 2019
      • January 2019
      • November 2018
    • Blog
  • Awareness
    • The Face of Alzheimer’s
    • Better Your Brain
    • World Alzheimer’s Day
  • Contact
  • Search
Cure Alzheimer's Fund Cure Alzheimer's Fund
  • 781-237-3800
  • Donate
  • Contact
  • Search

News and Events


Stay updated on the work of our researchers and advances in Alzheimer's science, funding and awareness

CUREALZ

Events

Interviews

News

Press

Videos

Webinars


February 10 2021

First Inaugural Robert D. Moir Symposium

A WEBINAR WITH CRESSET CAPITAL FEATURING HENRY MCCANCE AND RUDY TANZI

Public Service Announcement: Title — Night Sky (60 Seconds)

Public Service Announcement: Title — The Call (60 Seconds)

A Conversation Between Good Friends Lisa Genova and Greg O’Brien

November 5 2020

7:09 pm

Join Us For A Conversation Between Lisa Genova & Greg O’Brien: Dec 1st, 5:30 PM

October 23 2020

VARIATION IN TAU AMONG ALZHEIMER’S PATIENTS MAY EXPLAIN WHY SOME PEOPLE DECLINE AT A FASTER RATE THAN OTHERS

October 23 2020

AMYLYX PHARMACEUTICALS ANNOUNCES COMPLETION OF ENROLLMENT IN THE PEGASUS TRIAL OF AMX0035 IN ALZHEIMER’S DISEASE

October 23 2020

BRAIN IMAGING STUDY SUGGESTS FEMALE-SPECIFIC RISK FACTORS FOR ALZHEIMER’S DISEASE

October 23 2020

FDA Approves First Tau Imaging Agent For PET Scans For Diagnosis of Alzheimer’s Disease

October 23 2020

How Assessing Blood-Brain Barrier Damage in APOE4 Carriers May Predict Cognitive Decline

Reasons for Hope: Webinar with Dr. Ron Petersen, Alzheimer’s Disease and Clinical Trials

More

Register for email updates about our latest news:

© 2005 - 2021 Cure Alzheimer's Fund. All rights reserved.

Cure Alzheimer’s Fund is a “doing business as” name for the Alzheimer’s Disease Research Foundation, a 501(c)(3) public charity with federal tax ID #52-239-6428.

Privacy Policy

Donate | 100% goes directly to research

  • Contact
  • 781-237-3800
  • Sitemap